We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
WuXi AppTec and Schrödinger unveiled Faxian Therapeutics, a joint venture aimed at accelerating drug discovery. The new company will use Schrödinger’s computational drug
Tissue-engineered heart valves are an attractive treatment for heart valve disease, but they tend to change shape and stop working after only a few months.